Tr1 cell-mediated protection against autoimmune disease by intranasal administration of a fusion protein targeting cDC1 cells.

Hansson, Charlotta; Lebrero-Fernández, Cristina; Schön, Karin; Angeletti, Davide; Lycke, Nils

Hansson, Charlotta; Lebrero-Fernández, Cristina; Schön, Karin; Angeletti, Davide; Lycke, Nils.

Afiliação

Hansson C; Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.
Lebrero-Fernández C; Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.
Schön K; Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.
Angeletti D; Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden. Electronic address: davide.angeletti@gu.se.
Lycke N; Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.

Mucosal Immunol ; 16(4): 486-498, 2023 08.

Article em En | MEDLINE | ID: mdl-37192682

Assuntos

Esclerose Múltipla; Linfócitos T Reguladores; Humanos; Administração Intranasal; Toxina da Cólera; Linfócitos T CD4-Positivos; Esclerose Múltipla/tratamento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T Reguladores / Esclerose Múltipla Limite: Humans Idioma: En Revista: Mucosal Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suécia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google